Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gross Margin % is calculated as gross profit divided by its revenue. Telesis Bio's Gross Profit for the
three
months ended in Jun. 2024 was $-0.80 Mil. Telesis Bio's Revenue for the
three
months ended in Jun. 2024 was $1.55 Mil. Therefore, Telesis Bio's Gross Margin % for the quarter that ended in Jun. 2024 was -51.55%.
The historical rank and industry rank for Telesis Bio's Gross Margin % or its related term are showing as below:
TBIO's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 52.115 * Ranked among companies with meaningful Gross Margin % only.
Telesis Bio had a gross margin of -51.55% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Telesis Bio was 0.00% per year.
Telesis Bio (OTCPK:TBIO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Telesis Bio had a gross margin of -51.55% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Telesis Bio Gross Margin % Related Terms
Telesis Bio Gross Margin % Historical Data
* Premium members only.
The historical data trend for Telesis Bio's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Telesis Bio's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telesis Bio Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Telesis Bio's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Telesis Bio's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Telesis Bio (TBIO) has a Gross Margin % of -51.55% as of Jun. 2024. Gross margin is the ratio of total gross profit to net sales. View historical data on Telesis Bio and its competitors.
Is Telesis Bio's Gross Margin % too high?
Telesis Bio's current Gross Margin % is -51.55%. Overall, Telesis Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Telesis Bio's Gross Margin % compare to MHTX and ABT?
Telesis Bio's Gross Margin % of -51.55% can be compared against companies in the Medical Devices & Instruments industry. The industry median Gross Margin % is 52.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Telesis Bio and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telesis Bio's current Gross Margin % is -51.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telesis Bio stock overvalued right now?
Telesis Bio (TBIO) has a current Gross Margin % of -51.55%. The current Gross Margin % is -51.55%. Telesis Bio's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Telesis Bio (TBIO), the current Gross Margin % is -51.55% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
12GF Score
Get the complete analysis for TBIO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TBIO has been successfully added to your 
